[18F]-PET Radiopharmaceuticals with a Marketing Authorization in the Czech Republic or in the Slovak Republic

  • marked by the most common PET radionuclide 18F with half-life 109.8 min and maximum positron energy 633 keV
  • carrier-free, sterile and apyrogenic radiodiagnostice
  • intravenous application


  • the most common PET radiopharmaceutical for imaging of deposits in the tissues with the intensive metabolism of glucose
  • used in imaging of an increased consumption of glucose in the brain, heart and tumorous deposits in tissues (diagnosis, staging a monitoring of the used therapy of tumor diseases)

[18F]Natrium Fluoride

  • the preparation intended for topographical analysis of the regional alterations in the skeleton and for in vivo determination of the entire metabolic flow in the skeleton (primary and secondary malignant tumors of the skeleton and joint diseases)


  • the preparation intended for diagnostics of the quickly proliferative tumors, especially in brain and lung